BIOMAT Database Logo BIOMAT Database Logo

Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass. 2007

Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Nanoscience Centre, University of Cambridge, JJ Thomson Avenue, Cambridge, United Kingdom.

Aggregation of proteins and peptides is a widespread and much-studied problem, with serious implications in contexts ranging from biotechnology to human disease. An understanding of the proliferation of such aggregates under specific conditions requires a quantitative knowledge of the kinetics and thermodynamics of their formation; measurements that to date have remained elusive. Here, we show that precise determination of the growth rates of ordered protein aggregates such as amyloid fibrils can be achieved through real-time monitoring, using a quartz crystal oscillator, of the changes in the numbers of molecules in the fibrils from variations in their masses. We show further that this approach allows the effect of other molecular species on fibril growth to be characterized quantitatively. This method is widely applicable, and we illustrate its power by exploring the free-energy landscape associated with the conversion of the protein insulin to its amyloid form and elucidate the role of a chemical chaperone and a small heat shock protein in inhibiting the aggregation reaction.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D006046 Gold A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
D006360 Heat-Shock Proteins Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Stress Protein,Stress Proteins,Heat-Shock Protein,Heat Shock Protein,Heat Shock Proteins,Protein, Stress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Kinetics and thermodynamics of amyloid fibril assembly.
September 2006, Accounts of chemical research,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Thermodynamics of amyloid fibril formation from chemical depolymerization.
December 2019, Physical chemistry chemical physics : PCCP,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Thermodynamics of beta-amyloid fibril formation.
May 2004, The Journal of chemical physics,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth.
May 2013, Journal of the American Chemical Society,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Chemical Kinetics for Bridging Molecular Mechanisms and Macroscopic Measurements of Amyloid Fibril Formation.
April 2018, Annual review of physical chemistry,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Insights into amyloid fibril formation from mass spectrometry.
January 2006, Protein and peptide letters,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Stability matters, too - the thermodynamics of amyloid fibril formation.
September 2022, Chemical science,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Thermodynamics of amyloid fibril formation from non-equilibrium experiments of growth and dissociation.
April 2021, Biophysical chemistry,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Modelling amyloid fibril formation kinetics: mechanisms of nucleation and growth.
September 2013, Journal of physics. Condensed matter : an Institute of Physics journal,
Tuomas P J Knowles, and Wenmiao Shu, and Glyn L Devlin, and Sarah Meehan, and Stefan Auer, and Christopher M Dobson, and Mark E Welland
Amyloid fibril formation from crude protein mixtures.
January 2011, Biotechnology progress,
Copied contents to your clipboard!